News & Analysis on Clinical Trial Services & Contract Research And Development
New Mexico-headquartered drugmaker CytoDyn has begun the good manufacturing practice (GMP) standard production of the developmental candidate anti-HIV monoclonal antibody Cytolin (lymphocyte function-associated antigen-1).
Pharmaceutical manufacturers in Vietnam have gained a reprieve after the Ministry of Health (MoH) informed them that those without good manufacturing practice (GMP) certificates can continue production for now.
A deal to sell Pfizer's active pharmaceutical ingredient manufacturing (API) plant in County Cork, Ireland, has fallen through according to a statement by the US drug giant, placing over 180 production jobs under threat.